FGL1 and cervical carcinoma: Recently, tRF-Glu49 expression was found to be significantly downregulated in cervical cancer, and studies have shown that tRF-Glu49 inhibits cervical cancer proliferation, migration, and invasion by targeting fibrinogen-like protein 1(FGL1).